ClinicalTrials.gov
ClinicalTrials.gov Menu

Tanespimycin and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00096005
Recruitment Status : Terminated
First Posted : November 9, 2004
Last Update Posted : February 24, 2014
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : March 2010
  Study Completion Date : No date given